Literature DB >> 17549723

Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow.

Michaela Endres1, Katja Neumann, Thomas Häupl, Christoph Erggelet, Jochen Ringe, Michael Sittinger, Christian Kaps.   

Abstract

Microfracture is a frequently used reparative technique that induces a healing response in articular cartilage defects. Penetration of the subchondral bone leads to blood clot formation, allows multipotent mesenchymal cells to access the defect and, subsequently, leads to cartilaginous repair tissue. The aim of our study was to analyze the chemotactic recruitment of human subchondral spongious bone marrow-derived cells by synovial fluid (SF) from normal donors (ND), patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Subchondral spongious bone marrow-derived mesenchymal progenitors were isolated from bone cylinders after high tibial osteotomy and analyzed for the presence of stem cell-related cell surface antigens by flow cytometry. Recruitment of subchondral progenitors by normal SF and SF from donors with degenerated joint diseases was documented by using a modified Boyden chamber chemotaxis assay. The chemotaxis assay demonstrated that synovial fluid has the potential to recruit mesenchymal progenitors in vitro. SF from normal donors and patients with OA showed no difference in the potential to stimulate cell migration. SF obtained from RA donors showed significantly reduced cell recruitment compared to SF derived from OA patients (p = 0.0054) and normal donors (p < 0.0001). The chemotactic activity of SF obtained from normal donors and from patients with degenerative joint diseases suggests that SF may be actively involved in the migration of progenitors in cartilage defects after microfracture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549723     DOI: 10.1002/jor.20394

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  14 in total

Review 1.  [Regenerative potential of human adult precursor cells: cell therapy--an option for treating cartilage defects?].

Authors:  T Dehne; M Tschirschmann; R Lauster; M Sittinger
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

Review 2.  Regenerative medicine in rheumatic disease-progress in tissue engineering.

Authors:  Jochen Ringe; Gerd R Burmester; Michael Sittinger
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 3.  Mesenchymal stem cells in the treatment of pediatric diseases.

Authors:  Guo-Ping Zheng; Meng-Hua Ge; Qiang Shu; Mauricio Rojas; Jianguo Xu
Journal:  World J Pediatr       Date:  2013-08-09       Impact factor: 2.764

4.  Chondrogenic differentiation of human subchondral progenitor cells is affected by synovial fluid from donors with osteoarthritis or rheumatoid arthritis.

Authors:  Jan Philipp Krüger; Michaela Endres; Katja Neumann; Bruno Stuhlmüller; Lars Morawietz; Thomas Häupl; Christian Kaps
Journal:  J Orthop Surg Res       Date:  2012-03-13       Impact factor: 2.359

5.  Augmentation Strategies following the Microfracture Technique for Repair of Focal Chondral Defects.

Authors:  Eric J Strauss; Joseph U Barker; James S Kercher; Brian J Cole; Kai Mithoefer
Journal:  Cartilage       Date:  2010-04       Impact factor: 4.634

Review 6.  Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives.

Authors:  Eduardo Branco de Sousa; Priscila Ladeira Casado; Vivaldo Moura Neto; Maria Eugenia Leite Duarte; Diego Pinheiro Aguiar
Journal:  Stem Cell Res Ther       Date:  2014-10-03       Impact factor: 6.832

7.  Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells.

Authors:  He Liu; Jianxun Ding; Jincheng Wang; Yinan Wang; Modi Yang; Yanbo Zhang; Fei Chang; Xuesi Chen
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

8.  Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma Administration.

Authors:  Emma Muiños-López; Diego Delgado; Pello Sánchez; Bruno Paiva; Eduardo Anitua; Nicolás Fiz; Beatriz Aizpurua; Jorge Guadilla; Sabino Padilla; Froilán Granero-Moltó; Felipe Prósper; Mikel Sánchez
Journal:  Stem Cells Int       Date:  2016-10-12       Impact factor: 5.443

Review 9.  Tissue engineering in the rheumatic diseases.

Authors:  Jochen Ringe; Michael Sittinger
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

10.  Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone.

Authors:  Jeong-Eun Huh; Yeon-Cheol Park; Byung-Kwan Seo; Jae-Dong Lee; Yong-Hyeon Baek; Do-Young Choi; Dong-Suk Park
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.